Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manja Lang

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Endocrinology|October 13, 2009
In vivo characterization of high Basal signaling from the ghrelin receptorPia Steen Petersen, David P D Woldbye, Andreas Nygaard Madsen, et al.
ACS Chemical Biology|August 5, 2011
Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neuronsNigel Ramsden, Jessica Perrin, Zhao Ren, et al.
The Journal of Biological Chemistry|March 16, 2011
Unique interaction pattern for a functionally biased ghrelin receptor agonistBjørn Sivertsen, Manja Lang, Thomas M Frimurer, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Endocrinology|October 13, 2009
In vivo characterization of high Basal signaling from the ghrelin receptorPia Steen Petersen, David P D Woldbye, Andreas Nygaard Madsen, et al.
ACS Chemical Biology|August 5, 2011
Chemoproteomics-based design of potent LRRK2-selective lead compounds that attenuate Parkinson's disease-related toxicity in human neuronsNigel Ramsden, Jessica Perrin, Zhao Ren, et al.
The Journal of Biological Chemistry|March 16, 2011
Unique interaction pattern for a functionally biased ghrelin receptor agonistBjørn Sivertsen, Manja Lang, Thomas M Frimurer, et al.
Pageof 2